Mirai Bio

About:

Mirai Bio provides access to end-to-end development capabilities with innovation at every step.

Twitter/X: mirai_bio

Top Investors: Flagship Pioneering

Description:

Mirai Bio has developed an open platform powered by AI to address the main drawbacks and manufacturing to develop the future of genetic medicine.

Total Funding Amount:

$50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2021-01-01

Founders:

Geoffrey von Maltzahn, Hari Pujar

Number of Employees:

11-50

Last Funding Date:

2024-09-26

IPO Status:

Private

Industries: